Ferentino, Italy

Ferentino is a 14,034 m2 (151,061 ft2) facility specializing in integrated sterile liquid and lyophilized product development and commercial manufacturing, including high potency products and LVP.

Specialized capabilities include:

  • Sterile Liquid vials (SVP & LVP)
  • Biopharmaceuticals, including:
    • Monoclonal antibodies
    • Other recombinant proteins
  • Monoclonal antibodies
  • Proteins
  • Peptides
  • Sterile Lyophilized vials
  • Secondary packaging (vials)
  • Small molecules
  • Scale up
  • Blood product

Our Ferentino Facility has high-potency capabilities up to category 3b for commercial and development projects, and has received regulatory approval from:

  • AIFA (Agenzia Italiana del Farmaco)
  • FDA (Food and Drug Administration)
  • ANVISA (Brazilian Ministry of Health)
  • MFDS (Ministry of Food and Drug Safety Korea)
  • Turkey MoH
  • Health Canada
  • Japan PMDA (Pharm. and Med. Dev. Agency)
  • TFDA (Taiwan Food and Drug Administration)
  • Russian Certificate of Center

Learn more about the specific equipment and capabilities at this site by downloading our Site Fact Sheet.